vs
Cytek Biosciences, Inc.（CTKB）与Quanterix Corp（QTRX）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Quanterix Corp的1.4倍（$62.1M vs $43.9M）。Quanterix Corp净利率更高（-52.7% vs -70.9%，领先18.2%）。Quanterix Corp同比增速更快（24.7% vs 8.1%）。Cytek Biosciences, Inc.自由现金流更多（$-1.8M vs $-16.5M）。过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 16.9%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Quanterix Corp是一家生命科学企业，研发、生产和销售超高灵敏度单分子检测诊断平台、试剂及检测服务，覆盖肿瘤、神经退行性疾病、传染病等领域，为全球科研机构、生物制药企业及临床实验室提供研究、药物开发及临床诊断相关支持。
CTKB vs QTRX — 直观对比
营收规模更大
CTKB
是对方的1.4倍
$43.9M
营收增速更快
QTRX
高出16.6%
8.1%
净利率更高
QTRX
高出18.2%
-70.9%
自由现金流更多
CTKB
多$14.8M
$-16.5M
两年增速更快
CTKB
近两年复合增速
16.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $43.9M |
| 净利润 | $-44.1M | $-23.1M |
| 毛利率 | 52.9% | 45.7% |
| 营业利润率 | -9.0% | -56.4% |
| 净利率 | -70.9% | -52.7% |
| 营收同比 | 8.1% | 24.7% |
| 净利润同比 | -557.1% | -98.8% |
| 每股收益（稀释后） | — | $-0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBQTRX
| Q4 25 | $62.1M | $43.9M | ||
| Q3 25 | $52.3M | $40.2M | ||
| Q2 25 | $45.6M | $24.5M | ||
| Q1 25 | $41.5M | $30.3M | ||
| Q4 24 | $57.5M | $35.2M | ||
| Q3 24 | $51.5M | $35.8M | ||
| Q2 24 | $46.6M | $34.4M | ||
| Q1 24 | $44.9M | $32.1M |
净利润CTKBQTRX
| Q4 25 | $-44.1M | $-23.1M | ||
| Q3 25 | $-5.5M | $-33.5M | ||
| Q2 25 | $-5.6M | $-30.0M | ||
| Q1 25 | $-11.4M | $-20.5M | ||
| Q4 24 | $9.6M | $-11.6M | ||
| Q3 24 | $941.0K | $-8.4M | ||
| Q2 24 | $-10.4M | $-7.4M | ||
| Q1 24 | $-6.2M | $-11.2M |
毛利率CTKBQTRX
| Q4 25 | 52.9% | 45.7% | ||
| Q3 25 | 52.7% | 42.8% | ||
| Q2 25 | 52.3% | 46.2% | ||
| Q1 25 | 48.6% | 54.1% | ||
| Q4 24 | 58.5% | 63.0% | ||
| Q3 24 | 56.3% | 56.3% | ||
| Q2 24 | 54.6% | 64.7% | ||
| Q1 24 | 51.3% | 57.8% |
营业利润率CTKBQTRX
| Q4 25 | -9.0% | -56.4% | ||
| Q3 25 | -17.6% | -92.8% | ||
| Q2 25 | -23.3% | -151.6% | ||
| Q1 25 | -36.1% | -86.9% | ||
| Q4 24 | 5.2% | -42.0% | ||
| Q3 24 | -8.2% | -32.8% | ||
| Q2 24 | -18.3% | -31.8% | ||
| Q1 24 | -23.9% | -47.3% |
净利率CTKBQTRX
| Q4 25 | -70.9% | -52.7% | ||
| Q3 25 | -10.5% | -83.3% | ||
| Q2 25 | -12.2% | -122.6% | ||
| Q1 25 | -27.5% | -67.6% | ||
| Q4 24 | 16.8% | -33.1% | ||
| Q3 24 | 1.8% | -23.3% | ||
| Q2 24 | -22.4% | -21.5% | ||
| Q1 24 | -13.8% | -34.8% |
每股收益（稀释后）CTKBQTRX
| Q4 25 | — | $-0.48 | ||
| Q3 25 | — | $-0.73 | ||
| Q2 25 | — | $-0.77 | ||
| Q1 25 | — | $-0.53 | ||
| Q4 24 | — | $-0.30 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.19 | ||
| Q1 24 | — | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $29.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $295.7M |
| 总资产 | $461.5M | $418.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBQTRX
| Q4 25 | $90.9M | $29.8M | ||
| Q3 25 | $93.3M | $38.3M | ||
| Q2 25 | $75.5M | $132.9M | ||
| Q1 25 | $95.3M | $76.5M | ||
| Q4 24 | $98.7M | $56.7M | ||
| Q3 24 | $162.3M | $29.3M | ||
| Q2 24 | $177.9M | $47.0M | ||
| Q1 24 | $168.8M | $45.3M |
股东权益CTKBQTRX
| Q4 25 | $341.7M | $295.7M | ||
| Q3 25 | $378.6M | $314.5M | ||
| Q2 25 | $377.6M | $292.5M | ||
| Q1 25 | $379.6M | $316.4M | ||
| Q4 24 | $395.7M | $330.0M | ||
| Q3 24 | $385.5M | $338.9M | ||
| Q2 24 | $389.1M | $340.8M | ||
| Q1 24 | $392.6M | $343.4M |
总资产CTKBQTRX
| Q4 25 | $461.5M | $418.8M | ||
| Q3 25 | $494.9M | $444.1M | ||
| Q2 25 | $493.3M | $375.6M | ||
| Q1 25 | $482.6M | $396.5M | ||
| Q4 24 | $499.5M | $406.5M | ||
| Q3 24 | $491.2M | $411.0M | ||
| Q2 24 | $483.7M | $415.9M | ||
| Q1 24 | $492.1M | $414.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-16.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-16.5M |
| 自由现金流率自由现金流/营收 | -2.9% | -37.7% |
| 资本支出强度资本支出/营收 | 1.6% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-80.0M |
8季度趋势，按日历期对齐
经营现金流CTKBQTRX
| Q4 25 | $-771.0K | $-16.4M | ||
| Q3 25 | $-3.9M | $-41.2M | ||
| Q2 25 | $108.0K | $-5.7M | ||
| Q1 25 | $-125.0K | $-13.9M | ||
| Q4 24 | $2.0M | $-4.3M | ||
| Q3 24 | $13.2M | $-5.7M | ||
| Q2 24 | $6.2M | $-5.0M | ||
| Q1 24 | $4.0M | $-20.2M |
自由现金流CTKBQTRX
| Q4 25 | $-1.8M | $-16.5M | ||
| Q3 25 | $-4.6M | $-41.9M | ||
| Q2 25 | $-1.5M | $-6.4M | ||
| Q1 25 | $-974.0K | $-15.1M | ||
| Q4 24 | $1.1M | $-4.7M | ||
| Q3 24 | $12.2M | $-6.6M | ||
| Q2 24 | $5.2M | $-6.5M | ||
| Q1 24 | $3.4M | $-20.7M |
自由现金流率CTKBQTRX
| Q4 25 | -2.9% | -37.7% | ||
| Q3 25 | -8.7% | -104.2% | ||
| Q2 25 | -3.2% | -26.3% | ||
| Q1 25 | -2.3% | -49.9% | ||
| Q4 24 | 1.9% | -13.4% | ||
| Q3 24 | 23.7% | -18.4% | ||
| Q2 24 | 11.0% | -19.1% | ||
| Q1 24 | 7.6% | -64.5% |
资本支出强度CTKBQTRX
| Q4 25 | 1.6% | 0.2% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 3.2% | ||
| Q1 25 | 2.0% | 4.1% | ||
| Q4 24 | 1.6% | 1.2% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 2.3% | 4.7% | ||
| Q1 24 | 1.3% | 1.6% |
现金转化率CTKBQTRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
QTRX
| Products | $29.2M | 67% |
| Consumable And Other Products | $12.7M | 29% |
| Service Type Warranties | $1.7M | 4% |
